Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Uterine Cervical Neoplasms 1 Myasthenia Gravis 1 Kidney Neoplasms 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

aldesleukin 26 Sunitinib 25 Interferon-alpha 21 Everolimus 18 Sorafenib 16 Cyclophosphamide 16 Filgrastim 13 Bevacizumab 13 Nivolumab 11 Gemcitabine 11 Interleukin-2 10 Axitinib 10 fludarabine phosphate 9 Gene Expression Profiling 9 temsirolimus 8 Peripheral Blood Stem Cell Transplantation 8 Doxorubicin 8 pembrolizumab 7 Radiotherapy 6 Radiosurgery 6 Polymerase Chain Reaction 6 Ipilimumab 6 Carboplatin 6 sargramostim 5 Ifosfamide 5 Fluorouracil 5 Erlotinib Hydrochloride 5 Capecitabine 5 Bortezomib 5 atezolizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Kidney Neoplasms × Genotype × Clear all

NCT02404584 2025-12-04

GenCInibs-Suni

Centre Hospitalier Universitaire de Nīmes

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡